000 | 01819 a2200493 4500 | ||
---|---|---|---|
005 | 20250517165129.0 | ||
264 | 0 | _c20180530 | |
008 | 201805s 0 0 eng d | ||
022 | _a1098-6596 | ||
024 | 7 |
_a10.1128/AAC.01226-17 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aLei, Guang-Sheng | |
245 | 0 | 0 |
_aMechanisms of Action of Vitamin D as Supplemental Therapy for Pneumocystis Pneumonia. _h[electronic resource] |
260 |
_bAntimicrobial agents and chemotherapy _c10 2017 |
||
500 | _aPublication Type: Journal Article | ||
650 | 0 | 4 | _aAnimals |
650 | 0 | 4 |
_aAnti-Bacterial Agents _xtherapeutic use |
650 | 0 | 4 |
_aAntimicrobial Cationic Peptides _xbiosynthesis |
650 | 0 | 4 |
_aAutophagy-Related Protein 5 _xbiosynthesis |
650 | 0 | 4 |
_aBeclin-1 _xbiosynthesis |
650 | 0 | 4 | _aDrug Synergism |
650 | 0 | 4 | _aFemale |
650 | 0 | 4 |
_aGlutamate-Cysteine Ligase _xbiosynthesis |
650 | 0 | 4 |
_aGlutathione Reductase _xbiosynthesis |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 |
_aInterferon-gamma _xbiosynthesis |
650 | 0 | 4 |
_aInterleukin-6 _xbiosynthesis |
650 | 0 | 4 |
_aMacrophages, Alveolar _ximmunology |
650 | 0 | 4 | _aMice |
650 | 0 | 4 | _aMice, Inbred C57BL |
650 | 0 | 4 |
_aNitric Oxide Synthase Type II _xbiosynthesis |
650 | 0 | 4 |
_aPneumocystis _xdrug effects |
650 | 0 | 4 |
_aPneumonia, Pneumocystis _xdrug therapy |
650 | 0 | 4 |
_aPrimaquine _xtherapeutic use |
650 | 0 | 4 |
_aTrimethoprim, Sulfamethoxazole Drug Combination _xtherapeutic use |
650 | 0 | 4 |
_aTumor Necrosis Factor-alpha _xbiosynthesis |
650 | 0 | 4 |
_aVitamin D _xtherapeutic use |
650 | 0 | 4 | _aCathelicidins |
700 | 1 | _aZhang, Chen | |
700 | 1 | _aCheng, Bi-Hua | |
700 | 1 | _aLee, Chao-Hung | |
773 | 0 |
_tAntimicrobial agents and chemotherapy _gvol. 61 _gno. 10 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1128/AAC.01226-17 _zAvailable from publisher's website |
999 |
_c27419343 _d27419343 |